AR017436A1 - Una composicion farmaceutica en una dispersion molecular con biodisponibilidad mejorada - Google Patents

Una composicion farmaceutica en una dispersion molecular con biodisponibilidad mejorada

Info

Publication number
AR017436A1
AR017436A1 ARP980106455A ARP980106455A AR017436A1 AR 017436 A1 AR017436 A1 AR 017436A1 AR P980106455 A ARP980106455 A AR P980106455A AR P980106455 A ARP980106455 A AR P980106455A AR 017436 A1 AR017436 A1 AR 017436A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
molecular dispersion
biodisponibility
improved
improved biodisponibility
Prior art date
Application number
ARP980106455A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR017436A1 publication Critical patent/AR017436A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Una dispersion molecular, que comprende un compuesto que tiene la formula (I) molecularmente disperso en una matriz polimérica; una tableta y una cápsula.
ARP980106455A 1997-12-22 1998-12-17 Una composicion farmaceutica en una dispersion molecular con biodisponibilidad mejorada AR017436A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99716897A 1997-12-22 1997-12-22

Publications (1)

Publication Number Publication Date
AR017436A1 true AR017436A1 (es) 2001-09-05

Family

ID=25543717

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106455A AR017436A1 (es) 1997-12-22 1998-12-17 Una composicion farmaceutica en una dispersion molecular con biodisponibilidad mejorada

Country Status (28)

Country Link
EP (1) EP1039908B1 (es)
JP (2) JP2001526227A (es)
KR (1) KR100597331B1 (es)
CN (1) CN1116039C (es)
AR (1) AR017436A1 (es)
AT (1) ATE260105T1 (es)
AU (1) AU761994C (es)
BR (1) BR9813728A (es)
CA (1) CA2315685C (es)
CO (1) CO4970793A1 (es)
CZ (1) CZ295956B6 (es)
DE (1) DE69821984T2 (es)
DK (1) DK1039908T3 (es)
ES (1) ES2214757T3 (es)
HK (1) HK1027040A1 (es)
HU (1) HU229052B1 (es)
ID (1) ID28304A (es)
IL (1) IL136460A0 (es)
MY (1) MY126580A (es)
NO (1) NO327383B1 (es)
NZ (1) NZ504834A (es)
PE (1) PE20000012A1 (es)
PL (1) PL192423B1 (es)
PT (1) PT1039908E (es)
SK (1) SK285662B6 (es)
TW (1) TW527196B (es)
WO (1) WO1999032118A1 (es)
ZA (1) ZA9811592B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) * 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
EP1404300B1 (en) 2001-06-22 2009-09-30 Pfizer Products Inc. Pharmaceutical compositions of dispersions of drugs and neutral polymers
EP1492508A4 (en) * 2002-03-04 2009-05-06 Teva Pharma DOSAGE FORMS WITH CONTROLLED RELEASE
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008136393A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の結晶形およびその製造方法
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
JP3722293B2 (ja) * 1991-12-18 2005-11-30 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 新規な薬学的固体分散物
JPH0848632A (ja) * 1994-08-08 1996-02-20 Kanebo Ltd エトポシドを含有する固形組成物および固形製剤
PL185597B1 (pl) * 1995-12-22 2003-06-30 Schering Corp Tricykliczne amidy, środek farmaceutyczny i ich zastosowania
EP0954288B1 (en) * 1996-06-28 2004-08-11 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability

Also Published As

Publication number Publication date
HUP0100850A3 (en) 2002-12-28
JP2001526227A (ja) 2001-12-18
PL192423B1 (pl) 2006-10-31
AU1814399A (en) 1999-07-12
ID28304A (id) 2001-05-10
NO327383B1 (no) 2009-06-22
PE20000012A1 (es) 2000-01-18
NO20003235D0 (no) 2000-06-21
JP2010059212A (ja) 2010-03-18
CN1116039C (zh) 2003-07-30
ZA9811592B (en) 1999-06-17
HU229052B1 (en) 2013-07-29
AU761994C (en) 2004-01-08
HUP0100850A2 (hu) 2001-10-28
PL341344A1 (en) 2001-04-09
EP1039908B1 (en) 2004-02-25
HK1027040A1 (en) 2001-01-05
MY126580A (en) 2006-10-31
EP1039908A1 (en) 2000-10-04
ES2214757T3 (es) 2004-09-16
PT1039908E (pt) 2004-06-30
IL136460A0 (en) 2001-06-14
WO1999032118A1 (en) 1999-07-01
CO4970793A1 (es) 2000-11-07
BR9813728A (pt) 2000-10-10
DE69821984T2 (de) 2004-12-30
DK1039908T3 (da) 2004-05-03
KR100597331B1 (ko) 2006-07-10
SK8962000A3 (en) 2001-07-10
KR20010033397A (ko) 2001-04-25
CA2315685C (en) 2008-02-05
DE69821984D1 (de) 2004-04-01
AU761994B2 (en) 2003-06-12
NO20003235L (no) 2000-07-27
ATE260105T1 (de) 2004-03-15
NZ504834A (en) 2001-12-21
SK285662B6 (sk) 2007-05-03
TW527196B (en) 2003-04-11
CN1282245A (zh) 2001-01-31
CZ295956B6 (cs) 2005-12-14
CZ20002304A3 (cs) 2001-04-11
CA2315685A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
ATE395906T1 (de) Träger in partikelform zur verbesserung der oral- absorption von wikstoffen
CO5611097A2 (es) Tableta farmaceutica
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
BR9809025B1 (pt) polìmero anfótero, e, veìculo cosmeticamente aceitável.
DK0998304T3 (da) Farmaceutisk præparat. der omfatter et basisk lægemiddel, en cyclodextrin, en polymer og en syre
AR012409A1 (es) Sistemas y metodos para proteger el acceso a la informacion encriptada.
FI963496A (fi) Farmaseuttinen täyteaine, jolla on parempi puristettavuus
RS50407B (sr) Oralne formulacije opijatnog agonista otporne na mehaničke,termičke i/ili hemijske promene fizičkih osobina doznog oblika
DE69932144D1 (de) Pulverförmige pernasale mittel
AR069281A2 (es) Composicion farmaceutica de liberacion sostenida y uso de la misma para preparar medicamentos
BR9906070A (pt) Benzamidas substituìdas
DE68911208D1 (de) Selbstklebende, härtbare Organopolysiloxanzusammensetzung.
AR017436A1 (es) Una composicion farmaceutica en una dispersion molecular con biodisponibilidad mejorada
ES2148512T3 (es) Complejos de inclusion multicomponentes de alta solubilidad que constan de una sustancia farmaceutica acidica, una ciclodextrina y una base.
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
IT1306133B1 (it) Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
BR0015198A (pt) Combinação de dispositivo e embalagem de coloração de dente, e, matriz
FR2713444B1 (fr) Composition liquide désinfectante et ses utilisations.
RS50345B (sr) Vodena farmaceutska kompozicija koja sadrži ciklesonid
FI891364A0 (fi) Fast, vattenfri raney-katalysatordispersion.
DE69841260D1 (de) Bakterielle pheromone und deren verwendungen
ID21282A (id) Senyawa-senyawa cincin beranggota-5 terpadu yang disubstitusi sulfonamida, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung senyawa tersebut
ES2079554T3 (es) Mezclas de polimeros miscibles molecularmente.
BR9901387A (pt) Composições para a cura de polìmero.

Legal Events

Date Code Title Description
FG Grant, registration